| Reata Pharma licenses chronic kidney disease drug bardoxolone methyl to Kyowa ... - pharmabiz.com |
|
|
pharmabiz.comIn two phase-2 trials, bardoxolone significantly improved renal function in type-2 diabetic patients with advanced CKD. Ninety percent of patients in these ... read more |